Literature DB >> 17597153

Formation of amyloids by Abeta-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol.

Masaki Wakabayashi1, Katsumi Matsuzaki.   

Abstract

The conversion of soluble, non-toxic amyloid beta-protein (Abeta) to aggregated, toxic Abeta could be the key step in the development of Alzheimer's disease. Liposomal studies have proposed that Abeta-(1-40) preferentially recognizes a cholesterol-dependent cluster of gangliosides and a conformationally altered form of Abeta promotes the aggregation of the protein. Cell experiments using fluorescein-labeled Abeta-(1-40) supported this model. Here, the interaction of native Abeta-(1-42) with unfixed rat pheochromocytoma PC12 cells was visualized using the amyloid-specific dye Congo red. Abeta-(1-42) preferentially bound to ganglioside and cholesterol-rich domains of cell membranes and formed amyloids in a time-dependent manner. These observations corroborate the model involving ganglioside-mediated accumulation of Abeta. The NGF-induced differentiation of PC12 cells into neuron-like cells caused a marked increase in both gangliosides and cholesterol, and thereby greatly potentiated the accumulation and cytotoxicity of Abeta-(1-42). NGF-differentiated cells exposed to Abeta-(1-42) had degenerated neurites, in which ganglioside and cholesterol-rich domains were localized, preceding cell death. A reduction in the amount of cholesterol by the cholesterol synthesis inhibitor compactin almost nullified the formation of amyloids by Abeta-(1-42). Our system using NGF-differentiated PC12 cells and Congo red is useful for screening inhibitors of the formation of amyloids by and cytotoxicity of Abeta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597153     DOI: 10.1016/j.jmb.2007.06.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.

Authors:  Justin Legleiter; John D Fryer; David M Holtzman; Andtomasz Kowalewski
Journal:  ACS Chem Neurosci       Date:  2011-10-19       Impact factor: 4.418

2.  Measurement of the attachment and assembly of small amyloid-β oligomers on live cell membranes at physiological concentrations using single-molecule tools.

Authors:  Suman Nag; Jiji Chen; J Irudayaraj; S Maiti
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

Review 3.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

4.  Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol.

Authors:  Saurabh Trikha; Aleksandar M Jeremic
Journal:  J Biol Chem       Date:  2011-08-24       Impact factor: 5.157

5.  The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.

Authors:  David R Boyer; Binsen Li; Chuanqi Sun; Weijia Fan; Kang Zhou; Michael P Hughes; Michael R Sawaya; Lin Jiang; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

6.  HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures.

Authors:  M Y Aksenov; M V Aksenova; C F Mactutus; R M Booze
Journal:  Neurosci Lett       Date:  2010-04-02       Impact factor: 3.046

7.  Designed fluorescent probes reveal interactions between amyloid-beta(1-40) peptides and GM1 gangliosides in micelles and lipid vesicles.

Authors:  I Mikhalyov; A Olofsson; G Gröbner; L B-A Johansson
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

Review 8.  Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.

Authors:  Samuel A Kotler; Patrick Walsh; Jeffrey R Brender; Ayyalusamy Ramamoorthy
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

Review 9.  The Emerging Therapeutic Role of NGF in Alzheimer's Disease.

Authors:  Chao-Jin Xu; Jun-Ling Wang; Wei-Lin Jin
Journal:  Neurochem Res       Date:  2016-01-22       Impact factor: 3.996

10.  Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.

Authors:  Kathleen A Burke; Elizabeth A Yates; Justin Legleiter
Journal:  Front Neurol       Date:  2013-03-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.